Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate

Canadian Journal of Emergency Medicine

Volumn 9, Issue 1, 2007, Pages 40-42

  Sweet, David D ^a   Isac, G ^b   Morrison, B ^b   Fenwick, J ^b   Dhingra, V ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Etanercept; Purulent pericarditis; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIBIOTIC AGENT; ATENOLOL; ATROPINE; CLONIDINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOPAMINE; ESTRADIOL; ETANERCEPT; METHOTREXATE; METICILLIN; PHENYLEPHRINE; PREDNISONE; ROFECOXIB;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL PAIN; AGED; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HEART ARREST; HEART INFARCTION; HEART MASSAGE; HEART TAMPONADE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LOW DRUG DOSE; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PERICARDITIS; PURULENT PERICARDITIS; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; VITAL SIGN;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PERICARDITIS; RECEPTORS, TUMOR NECROSIS FACTOR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847137315     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Schluter D, Deckert M. The divergent role of tumour necrosis factor receptors in infectious diseases. Microbes Infect 2000; 2:1285-92.
2. Physicians' Desk reference. 56th ed. Montvale (NJ): Medical Economics; 2002. p. 1178-82.
3. Physicians' Desk reference. 56th ed. Montvale (NJ): Medical Economics; 2002. p. 1752-55.
4. Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists Infliximab and etanercept. Arthritis Rheum 2002;40:2565-70.
5. Keane K, Gershon S, Wise RP, et al. Tuberculosis associated with infiximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
6. Zhang Z, Correa H, Begue R. Tuberculosis and treatment with indiximab. N Engl J Med 2002;346:623-6.
7. Nakelchik M, Mangino JE. Reactivation of histoplasmosis after treatment with infliximab. Am J Med 2002;112:78.
8. Larry J, Goodman MD. Purulent pericarditis. Curr Treat Options Cardiovasc Med 2000;2:343-50.
9. Mann-Segal D, Shanahan E, Jones B, et al. Purulent pericarditis: rediscovery of an old remedy. J Thorac Cardiovasc Surg 1996; 111:487-8.
10. Arsura E, Kilgore W. Purulent pericarditis misdiagnosed as septic shock. South Med J 1999;92:285-8.
11. Schafer M. Lepori M. Intrapericardial urokinase irrigation and systemic corticosteroids: an alternative to pericardectomy for persistent fibrino-purulent pericarditis. Cardiovasc Surg 2002;10:508-11.
12. Boyle JD, Pearce ML. Purulent pericarditis: review of the literature and report of eleven cases. Medicine 1961;40:119-44.
13. Antoni C, Braun J. Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol 2002;20:152-7.
14. Baghai M, Osmon DR, Wolk DM, et al. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 2001;76:653-6.
15. Havell EA. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 1989;143:2894-9.
16. Rothe J, Lesslauer W, Lotscher H, et al. Mice lacking the tumor necrosis factor receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364:798-802.
17. Fisher CJ Jr, Agosti JM, Opal SM, et al. Soluble TNF receptor sepsis study group. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996;334:1697-702.
18. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 1998;56:2563-9.